Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Parkinson Disease ll: Pathophysiology

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...

Neural Regulation

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.

EPS and iPS Cells in Disease Research

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...

Parkinson Disease l: Introduction

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...

Parkinson's Disease: Treatment

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Synaptotagmin 13 is neuroprotective across motor neuron diseases.

Acta neuropathologica·2020

Same author

Motor neurons with differential vulnerability to degeneration show distinct protein signatures in health and ALS.

Neuroscience·2015

Same author

Schizophrenia-relevant behaviors in a genetic mouse model of constitutive Nurr1 deficiency.

Genes, brain, and behavior·2011

Same author

Migration at early age from a high to a lower coronary heart disease risk country lowers the risk of subclinical atherosclerosis in middle-aged men.

Journal of internal medicine·2009

Same author

Migration and differences in dietary habits-a cross sectional study of Finnish twins in Sweden.

European journal of clinical nutrition·2007

Same author

Adult mice with reduced Nurr1 expression: an animal model for schizophrenia.

Molecular psychiatry·2007

Search research articles

Related Experiment Video

Updated: Jun 20, 2026

Generation of Induced Neural Stem Cells from Peripheral Mononuclear Cells and Differentiation Toward Dopaminergic Neuron Precursors for Transplantation Studies

Generation of Induced Neural Stem Cells from Peripheral Mononuclear Cells and Differentiation Toward Dopaminergic Neuron Precursors for Transplantation Studies

Published on: July 11, 2019

Neuronal cell replacement in Parkinson's disease.

E Hedlund¹, T Perlmann

¹Ludwig Institute for Cancer Research Ltd, Stockholm, Sweden. eva.hedlund@licr.ki.se

Journal of Internal Medicine

|September 22, 2009

Summary

Cell therapy for Parkinson's disease using fetal dopamine neurons shows promise but faces challenges like dyskinesias and graft pathology. Future research focuses on stem cell-derived neurons for safer, more effective treatments.

More Related Videos

Directed Dopaminergic Neuron Differentiation from Human Pluripotent Stem Cells

Directed Dopaminergic Neuron Differentiation from Human Pluripotent Stem Cells

Published on: September 15, 2014

Locomotor Assessment of 6-Hydroxydopamine-induced Adult Zebrafish-based Parkinson's Disease Model

Locomotor Assessment of 6-Hydroxydopamine-induced Adult Zebrafish-based Parkinson's Disease Model

Published on: December 28, 2021

Related Experiment Videos

Last Updated: Jun 20, 2026

Generation of Induced Neural Stem Cells from Peripheral Mononuclear Cells and Differentiation Toward Dopaminergic Neuron Precursors for Transplantation Studies

Generation of Induced Neural Stem Cells from Peripheral Mononuclear Cells and Differentiation Toward Dopaminergic Neuron Precursors for Transplantation Studies

Published on: July 11, 2019

Directed Dopaminergic Neuron Differentiation from Human Pluripotent Stem Cells

Directed Dopaminergic Neuron Differentiation from Human Pluripotent Stem Cells

Published on: September 15, 2014

Locomotor Assessment of 6-Hydroxydopamine-induced Adult Zebrafish-based Parkinson's Disease Model

Locomotor Assessment of 6-Hydroxydopamine-induced Adult Zebrafish-based Parkinson's Disease Model

Published on: December 28, 2021

Area of Science:

Neuroscience
Regenerative Medicine
Cell Therapy

Background:

Parkinson's disease (PD) involves dopamine neuron loss.
Fetal dopamine neuron transplantation can restore motor function in PD patients.
Current cell therapies face challenges including abnormal involuntary movements (dyskinesias) and graft pathology.

Purpose of the Study:

To review the challenges and future directions of fetal dopamine neuron transplantation for Parkinson's disease.
To explore strategies for improving graft survival, function, and safety.
To discuss the potential of stem cell-derived dopamine neurons.

Main Methods:

Review of existing literature on fetal cell transplantation in Parkinson's disease.
Analysis of graft-related complications such as dyskinesias and Lewy body formation.
Discussion of alternative cell sources like embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs).

Main Results:

Fetal cell grafts can survive for over a decade but may exhibit pathology (Lewy bodies, reduced transporter expression).
Dyskinesias remain a significant side effect, potentially mitigated by specific neuronal enrichment (e.g., substantia nigra A9 dopamine neurons).
Graft longevity may be influenced by inflammatory responses and preparation methods.

Conclusions:

While fetal cell therapy offers symptomatic relief, issues of graft pathology and side effects necessitate further investigation.
Optimizing cell preparation and understanding host-graft interactions are crucial for improving outcomes.
Embryonic stem cell-derived and induced pluripotent stem cell-derived dopamine neurons represent a promising alternative for future Parkinson's disease cell therapy.